Clinical Trial: Efficacy and Safety of OsrhCT Before Upper Endoscopy on Improving Visualization of the Gastric Mucosa.

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07893600) titled 'Efficacy and Safety of OsrhCT Before Upper Endoscopy on Improving Visualization of the Gastric Mucosa.' on Oct. 19.

Brief Summary: Study was designed to evaluate efficacy and safety of OsrhCT before upper endoscopy on visibility of gastric mucosa.

A total of 40 subjects (both male and female) are expected to be enrolled in this trial.

Study Start Date: Oct. 27

Study Type: INTERVENTIONAL

Condition: Gastric Mucosal Lesion

Intervention: DRUG: Recombinant Human Chymotrypsin(OsrhCT) 4000U

Recombinant Human Chymotrypsin (OsrhCT), provided by Wuhan Healthgen Biotechnology Corporation, 4,000U/bag, freeze-dried powder

DRUG: Placebo ...